Brazil Cancer Drugs Market Clinical Trials Report 2024: Brazil Emerges as a Leading Force in Cancer Drug Clinical Trials
12 août 2024 04h44 HE
|
Research and Markets
Dublin, Aug. 12, 2024 (GLOBE NEWSWIRE) -- The "Brazil Cancer Drugs Clinical Trials Insight 2024" report has been added to ResearchAndMarkets.com's offering. With Brazil making significant strides...
Greenwich LifeSciences Announces $2.5 Million Private Placement
14 juin 2024 06h00 HE
|
Greenwich LifeSciences, Inc.
STAFFORD, Texas, June 14, 2024 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company" or "Greenwich"), a clinical-stage biopharmaceutical company focused on its Phase III...
Greenwich LifeSciences Extends Lock-up of Directors and Officers to June 30, 2025
13 mars 2024 06h00 HE
|
Greenwich LifeSciences, Inc.
STAFFORD, Texas, March 13, 2024 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial,...
Global Clinical Trial Kits Market Report Reveals Robust 8.57% CAGR up to 2034; Asia-Pacific Region Projected to Accelerate at Fastest Rate
12 mars 2024 13h21 HE
|
Research and Markets
Dublin, March 12, 2024 (GLOBE NEWSWIRE) -- The "Global Clinical Trial Kits Market Analysis & Forecast to 2024-2034: Market By Service; By Phase; By End-user; and By Region" report has been added...
Greenwich LifeSciences Flamingo-01 Phase III Clinical Trial Approved to Expand into Five Largest European Countries
27 févr. 2024 06h00 HE
|
Greenwich LifeSciences, Inc.
STAFFORD, Texas, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial,...
Greenwich LifeSciences Provides Update on Phase III Clinical Trial, Flamingo-01
14 févr. 2024 06h00 HE
|
Greenwich LifeSciences, Inc.
STAFFORD, Texas, Feb. 14, 2024 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on the development of GLSI-100, an...
Global Clinical Trials Market to Surge to $73.2 Billion by 2028, Driven by Demand for Specialized Testing Services and Outsourcing to CROs
09 févr. 2024 07h40 HE
|
Research and Markets
Dublin, Feb. 09, 2024 (GLOBE NEWSWIRE) -- The "Global Clinical Trials Market by Phase (Phase I, II, III), Service Type (Laboratory, Analytical Testing, Patient Recruitment, Protocol Designing),...
Global Clinical Trial Supplies Markets Report 2023-2028: Asia-Pacific Emerges as High-Growth Region, Increasing Decentralization Boosts Market Growth
08 janv. 2024 07h28 HE
|
Research and Markets
Dublin, Jan. 08, 2024 (GLOBE NEWSWIRE) -- The "Global Clinical Trial Supplies Market by Services (Manufacturing, Packaging, Logistics), Phases, Type (Small Molecules, Biologics), Therapeutic Areas...
World Edema Clinical Trials (Phase I, Phase II, Phase III, Phase IV) Market Size, Share & Trends Analysis Report 2023-2030
06 nov. 2023 06h23 HE
|
Research and Markets
Dublin, Nov. 06, 2023 (GLOBE NEWSWIRE) -- The "Edema Clinical Trials Market Size, Share & Trends Analysis Report By Phase (Phase I, Phase II, Phase III, Phase IV), By Participant (Pediatrics,...
Global Diabetes Devices and Therapeutics Report Offers Unparalleled Insights into Booming Market
24 oct. 2023 08h43 HE
|
Research and Markets
Dublin, Oct. 24, 2023 (GLOBE NEWSWIRE) -- In a world where diabetes is a growing concern, the latest research report, "Global Diabetes Devices and Therapeutics Business Investment Opportunities"...